Net profit of Concord Biotech declined 26.91% to Rs 42.57 crore in the quarter ended June 2025 as against Rs 58.24 crore during the previous quarter ended June 2024. Sales declined 5.47% to Rs 203.99 crore in the quarter ended June 2025 as against Rs 215.80 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 203.99 | 215.80 | -5 |
| OPM % | 30.10 | 37.66 | - |
| PBDT | 75.03 | 91.34 | -18 |
| PBT | 57.25 | 78.16 | -27 |
| NP | 42.57 | 58.24 | -27 |